Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Molitch

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Diabetes Care|November 30, 2006
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndromeGeorge Bakris, Mark Molitch, Ann Hewkin, et al.
Kidney International|May 20, 2003
Epigenetic and genetic analysis of p16 in dermal fibroblasts from type 1 diabetic patients with nephropathyLixia Zeng, Yashpal S Kanwar, Nail Amro, et al.
Journal of the American Society of Nephrology : JASN|March 5, 2011
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathyDonald E Kohan, Yili Pritchett, Mark Molitch, et al.
Kidney International|August 20, 2010
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce eventsGeorge Bakris, Joseph Vassalotti, Eberhard Ritz, et al.
Cardiology Journal|May 8, 2020
Exercise based assessment of cardiac autonomic function in type 1 versus type 2 diabetes mellitusJeffrey J Goldberger, Daniel J Pelchovitz, Jason Ng, et al.
Diabetes Care|June 16, 2012
A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiencyDavid Baldwin, Jennifer Zander, Christina Munoz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 11, 2022
KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKDAmy K Mottl, Radica Alicic, Christos Argyropoulos, et al.
Pain|September 1, 1990
Does capsaicin relieve the pain of diabetic neuropathy?David A Chad, Neil Aronin, Ruth Lundstrom, et al.
Diabetes Care|August 29, 2006
Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention ProgramElizabeth A Walker, Mark Molitch, M Kaye Kramer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2013
Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D studyPhyllis August, Regina M Hardison, Fadi G Hage, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Diabetes Care|November 30, 2006
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndromeGeorge Bakris, Mark Molitch, Ann Hewkin, et al.
Kidney International|May 20, 2003
Epigenetic and genetic analysis of p16 in dermal fibroblasts from type 1 diabetic patients with nephropathyLixia Zeng, Yashpal S Kanwar, Nail Amro, et al.
Journal of the American Society of Nephrology : JASN|March 5, 2011
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathyDonald E Kohan, Yili Pritchett, Mark Molitch, et al.
Kidney International|August 20, 2010
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce eventsGeorge Bakris, Joseph Vassalotti, Eberhard Ritz, et al.
Cardiology Journal|May 8, 2020
Exercise based assessment of cardiac autonomic function in type 1 versus type 2 diabetes mellitusJeffrey J Goldberger, Daniel J Pelchovitz, Jason Ng, et al.
Diabetes Care|June 16, 2012
A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiencyDavid Baldwin, Jennifer Zander, Christina Munoz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 11, 2022
KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKDAmy K Mottl, Radica Alicic, Christos Argyropoulos, et al.
Pain|September 1, 1990
Does capsaicin relieve the pain of diabetic neuropathy?David A Chad, Neil Aronin, Ruth Lundstrom, et al.
Diabetes Care|August 29, 2006
Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention ProgramElizabeth A Walker, Mark Molitch, M Kaye Kramer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2013
Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D studyPhyllis August, Regina M Hardison, Fadi G Hage, et al.
Pageof 4